Skip to main content

Table 3 Patients Characteristics at Baseline

From: An observational study on cough in children: epidemiology, impact on quality of sleep and treatment outcome

  Levodropropizine
(LDP) n = 101
Central Antitussives (CA) n = 60 No Treatment (NT) n = 80 p
* p < 0,05 LDP. vs CA
Age (years), mean (min-max) 5.9* (0.8-14.8) 7.3 (1.6-13.3) 6.3 (0.3-14.0) NS LDP vs NT
NS CA vs NT
Cough Duration (days), mean (min-max) 4.6 (2-15) 5.8 (2-21) 4.7 (2-17) NS
Cough Type (%)     
Productive 36.6% 25.0% 46.3% NS
Dry 50.5% 63.3% 40.0% NS
Mix 12.9% 11.7% 13.8% NS
Cough Intensity (%)     
Mild 7.9% 8.3% 42.5%* *p < 0.01 NT vs LDP/CA
Moderate 58.4% 53.3% 51.3% NS
Severe 33.7% 38.3% 6.3%* *p < 0.01 NT vs LDP/CA
Cough Frequency (%)     
Occasional 18.8% 10.0% 60.0% NS
Frequent 65.3% 75.0% 36.3% NS
Continuous 15.8% 15.0% 3.8%* *p < 0.01 NT vs LDP/CA